Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02459301 |
| Title | Dose-Ranging Study of IPH2201 in Patients With High Grade Serious CA of Ovarian, Fallopian Tube or Peritoneal Origin |
| Recruitment | Completed |
| Gender | female |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | NCIC Clinical Trials Group |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | CAN |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Cross Cancer Institute | Edmonton | Alberta | T6G 1Z2 | Canada | Details | |
| BCCA - Cancer Centre for the Southern Interior | Kelowna | British Columbia | V1Y 5L3 | Canada | Details | |
| BCCA - Vancouver Cancer Centre | Vancouver | British Columbia | V5Z 4E6 | Canada | Details | |
| Juravinski Cancer Centre at Hamilton Health Sciences | Hamilton | Ontario | L8V 5C2 | Canada | Details | |
| London Regional Cancer Program | London | Ontario | N6A 5W9 | Canada | Details | |
| University Health Network | Toronto | Ontario | M5G 2M9 | Canada | Details | |
| CHUM - Hopital Notre-Dame | Montreal | Quebec | H2L 4M1 | Canada | Details |